Echinococcus granulosus cyst fluid promotes activation and migration of hepatic stellate cells

doi:10.12140/j.issn.1000-7423.2025.01.011

Abstract

Abstract:

Objective To explore the effects and mechanisms of Echinococcus granulosus cyst fluid (CF) on the activation and migration of hepatic stellate cells (HSC). Methods Liver lesion tissues of cystic echinococcosis (CE) patients were obtained, and the fibrosis of liver tissues was observed using hematoxylin and eosin (HE) staining and Masson staining. HSCs were cultured in vitro for 48 and 72 hours in culture medium without CF and with 10%, 20% and 40% CF, respectively. Western blotting was used to detect the relative protein expression levels of α-mooth muscle actin (α-SMA), collagen type I alpha 1 (Col1a1), phosphatidylinositol 3 kinase (PI3K), phosphorylated PI3K (p-PI3K), protein kinase B (Akt) and phosphorylated Akt (p-Akt). Real-time quantitative PCR (qPCR) was used to detect the relative mRNA transcription levels of α-SMA, Col1a1 and Col3a1. Scratch assay and Transwell assays were conducted to assess the effects of CF on HSC migration. Results HE staining showed that the outer capsule of E. granulosus in the liver lesion tissues of CE patients was transparent and homogeneous with fibrous strips, and Masson staining showed a large amount of collagen fiber deposition in the outer capsule. Western blotting results showed that after 72 hours of intervention, the relative protein expression levels of α-SMA in the control group, 10% CF group, 20% CF group and 40% CF group were 0.359 ± 0.043, 0.641 ± 0.088, 0.900 ± 0.084 and 1.111 ± 0.027, respectively. The 10% CF group, 20% CF group, and 40% CF group had higher levels than the control group (t = 5.236, 10.050, 13.980; all P < 0.05). The relative expression levels of Col1a1 in each group were 0.392 ± 0.057, 0.546 ± 0.022, 0.854 ± 0.034 and 1.127 ± 0.057, respectively. The 10% CF group, 20% CF group and 40% CF group had higher levels than the control group (t = 4.228, 12.630, 20.090; all P < 0.05). qPCR results showed that after 72 hours of intervention, the relative mRNA transcription levels of α-SMA in the control group, 10% CF group, 20% CF group and 40% CF group were 1.000 ± 0.093, 1.437 ± 0.106, 1.453 ± 0.105 and 1.697 ± 0.154, respectively. The 10% CF group, 20% CF group and 40% CF group had higher levels than the control group (t = 4.604, 4.769, 7.339; all P < 0.05). The relative mRNA transcription levels of Col1a1 in each group were 0.856 ± 0.042, 1.067 ± 0.049, 1.283 ± 0.128 and 1.582 ± 0.046, respectively. The 20% CF group and 40% CF group had higher levels than the control group (t = 6.932, 11.790; both P < 0.05). The relative mRNA transcription levels of Col3a1 in each group were 0.611 ± 0.054, 0.908 ± 0.041, 1.000 ± 0.045 and 1.239 ± 0.101, respectively. The 10% CF group, 20% CF group and 40% CF group had higher levels than the control group (t = 5.599, 7.346, 11.850; all P < 0.05). Western blotting results showed that the relative protein expression levels of p-PI3K/PI3K in the control group, 10% CF group, 20% CF group and 40% CF group were 0.346 ± 0.050, 0.716 ± 0.054, 0.941 ± 0.114 and 1.276 ± 0.004, respectively. The 10% CF group, 20% CF group, and 40% CF group had higher levels than the control group (t = 6.669, 10.740, 16.780; all P < 0.01). The relative protein expression levels of p-Akt/Akt in each group were 0.524 ± 0.111, 0.815 ± 0.019, 1.043 ± 0.052 and 1.333 ± 0.054, respectively. The 10% CF group, 20% CF group and 40% CF group had higher levels than the control group (t = 5.268, 9.413, 14.670; all P < 0.01). Scratch assay results showed that after 24 hours of intervention, the cell migration rates in the 10% CF group, 20% CF group and 40% CF group were (73.6 ± 2.1)%, (88.2 ± 2.1)% and (96.5 ± 1.2)%, respectively, all higher than (55.1 ± 2.9)% in the control group (t = 10.510, 18.820, 23.540; all P < 0.05). Transwell assay results showed that after 24 hours of intervention, the average number of cells per field in the control group, 10% CF group, 20% CF group and 40% CF group were (62.333 ± 8.145), (82.333 ± 8.505), (132.333 ± 17.620) and (164.333 ± 11.060), respectively. The 20% CF group and 40% CF group had higher numbers than the control group (t = 7.173, 10.450; both P < 0.01). Conclusion E. granulosus CF could promote the activation of HSC and enhance their migration ability through the PI3K/Akt pathway.

Key words: Echinococcus granulosus, Hepatic stellate cells, Cyst fluid, Fibrosis

CLC Number:

R532.32

CUI Jie, WU Xiya, LIN Zhiyi, CAI Kefeng, WU Zhengzhan, XIONG Zitong, HUANG Yanxin, FANG Fuzhong, XIN Zirui, ZHANG Hongwei. Echinococcus granulosus cyst fluid promotes activation and migration of hepatic stellate cells[J]. CHINESE JOURNAL OF PARASITOLOGY AND PARASITIC DISEASES, 2025, 43(1): 69-75.

Figures/Tables 7

Table 1

Fig. 1

Fig. 2

Fig. 3

Fig. 4

Fig. 5

Fig. 6

References 25

[1]	吴川川, 张壮志, 李军, 等. 棘球蚴(包虫)病160年控制失败和成功经验教训及我国的控制对策[J]. 中国人兽共患病学报, 2024, 40(5): 464-470.
	Wu CC, Zhang ZZ, Li J, et al. Failures and successes learned from 160 years of echinococcosis control and countermeasures in China[J]. Chin J Zoonoses, 2024, 40(5): 464-470. (in Chinese)
[2]	McManus DP, Zhang W, Li J, et al. Echinococcosis[J]. Lancet, 2003, 362(9392): 1295-1304.
[3]	Wen H, Vuitton L, Tuxun T, et al. Echinococcosis: Advances in the 21st century[J]. Clin Microbiol Rev, 2019, 32(2): e00075-18.
[4]	Tamarozzi F, Deplazes P, Casulli A. Reinventing the wheel of Echinococcus granulosus sensu lato transmission to humans[J]. Trends Parasitol, 2020, 36(5): 427-434.
[5]	蒋小凤, 沈玉娟. 棘球蚴感染致肝纤维化的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(5): 656-660.
	Jiang XF, Shen YJ. Research progress on liver fibrosis caused by Echinococcus infection[J]. Chin J Parasitol Parasit Dis, 2022, 40(5): 656-660. (in Chinese)
[6]	张仁杰, 庞华胜, 李景中, 等. 棘球绦虫诱导肝纤维化机制研究进展[J]. 中国血吸虫病防治杂志, 2022, 34(6): 646-653.
	Zhang RJ, Pang HS, Li JZ, et al. Mechanism of hepatic fibrosis associated with Echinococcus: a review[J]. Chin J Schisto Control, 2022, 34(6): 646-653. (in Chinese)
[7]	Kitto LJ, Henderson NC. Hepatic stellate cell regulation of liver regeneration and repair[J]. Hepatol Commun, 2020, 5(3): 358-370.
[8]	Hammerich L, Tacke F. Hepatic inflammatory responses in liver fibrosis[J]. Nat Rev Gastroenterol Hepatol, 2023, 20(10): 633-646.
[9]	Luo NA, Li JB, Wei Y, et al. Hepatic stellate cell: a double-edged sword in the liver[J]. Physiol Res, 2021, 70(6): 821-829.
[10]	Trivedi P, Wang S, Friedman SL. The power of plasticity-metabolic regulation of hepatic stellate cells[J]. Cell Metab, 2021, 33(2): 242-257.
[11]	Barcena-Varela M, Colyn L, Fernandez-Barrena MG. Epigenetic mechanisms in hepatic stellate cell activation during liver fibrosis and carcinogenesis[J]. Int J Mol Sci, 2019, 20(10): 2507.
[12]	Yan YF, Zeng JF, Xing LH, et al. Extra- and intra-cellular mechanisms of hepatic stellate cell activation[J]. Biomedicines, 2021, 9(8): 1014.
[13]	王春生, 乌尔格力, 西利扎提?库来西, 等. 细粒棘球蚴囊液致敏过程中IL-1β受体阻滞剂对肺损伤的治疗作用[J]. 中国寄生虫学与寄生虫病杂志, 2024, 42(2): 199-203, 210.
	Wang CS, Wu E, Xilizati KLX, et al. Therapeutic effects of IL-1β receptor blocker on lung injury during the sensitization process of Echinococcus granulosus cyst fluid[J]. Chin J Parasitol Parasit Dis, 2024, 42(2): 199-203, 210. (in Chinese)
[14]	Kisseleva T, Brenner D. Molecular and cellular mechanisms of liver fibrosis and its regression[J]. Nat Rev Gastroenterol Hepatol, 2021, 18(3): 151-166.
[15]	The Surgical Professional Committee of Hydatid Disease of the Surgical Branch of the Chinese Medical Association. Expert consensus on the diagnosis and treatment of liver two types of echinococcosis (2019)[J]. Chin J Digest Surg, 2019, 18 (8): 711-721.
	中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2019 版)[J]. 中华消化外科杂志, 2019, 18(8): 711-721.
[16]	Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues[J]. Mol Aspects Med, 2019, 65: 37-55.
[17]	Peters L, Burkert S, Grüner B. Parasites of the liver: Epidemiology, diagnosis and clinical management in the European context[J]. J Hepatol, 2021, 75(1): 202-218.
[18]	何兴. 寄生虫感染所致肝纤维化的疾病负担及病理特征[J]. 中国热带医学, 2023, 23(10): 1058-1062, 1098.
	He X. Disease burden and pathological characteristics of hepatic fibrosis induced by parasite infection[J]. China Trop Med, 2023, 23(10): 1058-1062, 1098. (in Chinese)
[19]	高元, 胡媛, 曹建平. 免疫细胞对血吸虫病肝纤维化作用的研究进展[J]. 中国寄生虫学与寄生虫病杂志, 2022, 40(1): 88-93.
	Gao Y, Hu Y, Cao JP. Research progress on the role of immune cells in liver fibrosis due to schistosomiasis[J]. Chin J Parasitol Parasit Dis, 2022, 40(1): 88-93. (in Chinese)
[20]	Akk?z H, Gieseler RK, Canbay A. Liver fibrosis: From basic science towards clinical progress, focusing on the central role of hepatic stellate cells[J]. Int J Mol Sci, 2024, 25(14): 7873.
[21]	Kamm DR, McCommis KS. Hepatic stellate cells in physiology and pathology[J]. J Physiol, 2022, 600(8): 1825-1837.
[22]	Tsuchida T, Friedman SL. Mechanisms of hepatic stellate cell activation[J]. Nat Rev Gastroenterol Hepatol, 2017, 14(7): 397-411.
[23]	李涛, 李子华, 张翠影, 等. 人源细粒棘球蚴囊壁与囊液中宿主蛋白的鉴定与分析[J]. 中国寄生虫学与寄生虫病杂志, 2023, 41(6): 677-682.
	Li T, Li ZH, Zhang CY, et al. Identification and analysis of host proteins in the cyst wall and cyst fluid of Echinococcus granulosus in human infection[J]. Chin J Parasitol Parasit Dis, 2023, 41(6): 677-682. (in Chinese)
[24]	Hu QC, Zhang WW, Wei F, et al. Human diet-derived polyphenolic compounds and hepatic diseases: From therapeutic mechanisms to clinical utilization[J]. Phytother Res, 2024, 38(1): 280-304.
[25]	Shamsan E, Almezgagi M, Gamah M, et al. The role of PI3k/AKT signaling pathway in attenuating liver fibrosis: A comprehensive review[J]. Front Med (Lausanne), 2024, 11: 1389329.

基因 Gene	引物序列（5′→3′） Primer sequence (5′→3′)
α-SMA	F：CTATGAGGGCTATGCCTTGCC
	R：GCTCAGCAGTAGTAACGAAGGA
Col3a1	F：TTGAAGGAGGATGTTCCCATCT
	R：ACAGACACATATTTGGCATGGTT
Col1a1	F：GTGCGATGACGTGATCTGTGA
	R：CGGTGGTTTCTTGGTCGGT
β-actin	F：AGTGTGACGTTGACATCCGTA
	R：CCAGAGCAGTAATCTCCTTCT